Literature DB >> 31660016

Gvoke HypoPen: An Auto-Injector Containing an Innovative, Liquid-Stable Glucagon Formulation for Use in Severe Acute Hypoglycemia.

Damianne Brand-Eubanks1.   

Abstract

Entities:  

Year:  2019        PMID: 31660016      PMCID: PMC6794225          DOI: 10.2337/cd19-0040

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


× No keyword cloud information.
  4 in total

1.  Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems.

Authors:  Brett Newswanger; Steve Ammons; Neelima Phadnis; W Kenneth Ward; Jessica Castle; Robert W Campbell; Steven J Prestrelski
Journal:  J Diabetes Sci Technol       Date:  2015-01

Review 2.  Hypoglycemia in diabetes.

Authors:  Philip E Cryer; Stephen N Davis; Harry Shamoon
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

3.  Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach.

Authors:  Nitil Kedia
Journal:  Diabetes Metab Syndr Obes       Date:  2011-09-06       Impact factor: 3.168

4.  DrugBank 5.0: a major update to the DrugBank database for 2018.

Authors:  David S Wishart; Yannick D Feunang; An C Guo; Elvis J Lo; Ana Marcu; Jason R Grant; Tanvir Sajed; Daniel Johnson; Carin Li; Zinat Sayeeda; Nazanin Assempour; Ithayavani Iynkkaran; Yifeng Liu; Adam Maciejewski; Nicola Gale; Alex Wilson; Lucy Chin; Ryan Cummings; Diana Le; Allison Pon; Craig Knox; Michael Wilson
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.